Silicon Laboratories Inc (SLAB)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Silicon Laboratories Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 1 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 217.50 $ — 97% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
6 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -8.5% failed
- More than 10% revenue growth is expected for the coming year 16.0% passed
- Share count grows by less than 3% a year -3.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 42.7% passed
- Gross margin at 40% or higher and without meaningful erosion 58.2% passed
- Goodwill from acquisitions does not grow faster than revenue 29.7% failed
- Net debt below twice EBITDA 444 m net cash passed
- Operating cash flow covers the profits of the last three years 342 m passed
- Return on capital at 15% or higher, or up versus two years ago -6.3% failed
- Insiders hold at least 10% or are net buyers 1.7% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 2.5% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 11
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.81 | 2.61 – 3.17 | 925 | 205.5% | 9 |
| 12/31/2027 | 4.26 | 3.85 – 5.04 | 1,076 | 51.4% | 8 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.17 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.73 | – | 166 | 91.40 | -14.30 | 10 | 6 |
| 2025: Q1 | -0.94 | – | 178 | 67.10 | -17.10 | 48 | 43 |
| 2025: Q2 | -0.67 | – | 193 | 32.70 | -11.30 | 5 | -4 |
| 2025: Q3 | -0.30 | – | 206 | 23.80 | -4.80 | 34 | 28 |
| 2025: Q4 | -0.08 | – | 208 | 25.20 | -1.30 | 8 | -2 |
| 2026: Q1 | -0.48 | – | 214 | 20.10 | -7.40 | 5 | -5 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 698 | 66 | 61 | 1.45 | 129 | 827 | 1,082 |
| 2017 | 769 | 85 | 47 | 1.09 | 190 | 953 | 1,535 |
| 2018 | 868 | 85 | 84 | 1.90 | 174 | 1,067 | 1,624 |
| 2019 | 474 | -89 | 19 | 0.44 | 167 | 1,115 | 1,675 |
| 2020 | 511 | -107 | 13 | 0.28 | 136 | 1,200 | 1,993 |
| 2021 | 721 | -33 | 2,117 | 47.78 | -100 | 2,212 | 2,958 |
| 2022 | 1,024 | 119 | 91 | 2.54 | 72 | 1,405 | 2,169 |
| 2023 | 782 | -24 | -35 | -1.09 | -30 | 1,209 | 1,443 |
| 2024 | 584 | -165 | -191 | -5.93 | -14 | 1,080 | 1,223 |
| 2025 | 785 | -71 | -65 | -1.98 | 96 | 1,094 | 1,269 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Silicon Laboratories Inc., ein fabloses Halbleiterunternehmen, bietet analoglastige Mixed-Signal-Produkte in den USA, China, Taiwan und international an.
| Employees | 1,930 |
|---|---|
| Headquarters | Austin, TX |
| Address | 400 West Cesar Chavez, 78701 Austin, United States |
| Phone | 512 416 8500 |
| Website | silabs.com |
| IPO Date | 23. Mar 2000 |
| ISIN | US8269191024 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Robert Matthew Johnson | CEO, President & Director | 1976 |
| Dean Warren Butler | CFO & Senior VP | 1983 |
| Brandon Tolany | Senior Vice President of Worldwide Sales, Marketing & Applications | 1974 |
| Robert J. Conrad | Senior VP & GM | 1960 |
| Vu Do | Senior Vice President of Global Operations | – |
| Mark D. Mauldin | Chief Accounting Officer | 1970 |
| Daniel Cooley | Senior VP of Technology & Product Development and CTO | – |
| Thomas Haws | Investor Relations Manager | – |
| Nestor Ho Gutierrez J.D. | Chief Legal Officer and VP of Government Affairs & Public Policy | – |
| Serena Townsend | Chief People Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.